Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

Here's who will be speaking in 2018

Here's who spoke in 2018

 Are you interested in being part of our speaker faculty in 2019? Send an email to jbramwell@eyeforpharma.com for more information. 


Steven Hildemann

Steven Hildemann

Global Chief Medical Officer
Merck

Read more

More information coming soon...

Kris Sterkens

Kris Sterkens

Company Groups Chairman, Europe, Middle East and Africa
Janssen

Read more

Since starting his career at Janssen in Belgium almost 30 years ago, Kris Sterkens has been part of many teams across EMEA, Asia Pacific, and the United States.

Moving on from his latest role as the Company Group Chairman of Janssen Asia Pacific, Kris was appointed Company Group Chairman of Europe, Middle East and Africa in June 2017. He was excited to return to his home country, Belgium, after spending over three years in Singapore since February 2014 for the Asia Pacific business.

Under Kris’ stewardship, Janssen Asia Pacific achieved notable milestones, including a return to growth in China and a successful business transformation in Japan. Kris also led teams in Korea, Australia, and New Zealand and successfully competed against new biosimilar entrant, in addition to achieving industry-leading growth in India. Throughout his career, Kris has demonstrated exceptional leadership and an ability to identify and develop talent. For instance, in Asia Pacific, he introduced Company Group Chairman’s Dialogue, a talent development programme which has engaged more than 100 emerging leaders.

Prior to that, Kris was leading the EMEA Strategy Organisation, alongside his role as Managing Director of the region’s Mid-Sized Markets. He was also the Managing Director for Janssen the Netherlands, the Benelux countries, and then Germany from 2007–2012.

Before his transition into General Management, Kris was Vice President, Finance and Chief Finance Officer (CFO) for Janssen EMEA.

Kris holds a Master’s degree in Applied Economics from the University of Antwerp, a Master's degree in Financial Management from the Flemish Institute of Management, and an MBA from the Solvay Business School in Brussels. Kris is fluent in Dutch, English, German, and French and has been a frequent speaker at business schools, medical and patient group events, and industry meetings.

Shreeram Aradhye

Shreeram Aradhye

Chief Medical Officer, Global Head of Medical Affairs, Novartis

Read more

More information coming soon...

Sebastian Guth

Sebastian Guth

Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals

Read more

Sebastian Guth is Executive Vice President and Chief Marketing Officer for Bayer Pharmaceuticals. In addition, he is responsible for the P&L and entire operations of Bayer's global Radiology Business Unit. Mr. Guth is a member of the Pharmaceuticals Executive Committee and Global Pharmaceuticals Development Committee.

Based in Berlin, Germany, Mr. Guth oversees global product strategy, marketing, market access and marketing operations for Bayer’s prescription pharmaceuticals portfolio. Bayer Pharmaceuticals’ portfolio focuses on highly innovative new launches and a broad range of established products for cardiology and women’s healthcare as well as for specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Radiology Business Unit develops and commercializes diagnostic imaging equipment together with the necessary contrast agents.

Before assuming his current role at Bayer Pharmaceuticals in October 2015, Mr. Guth was Chief Marketing Officer for Bayer’s General Medicine Business. Previously he served as President & Chief Executive Officer of Bayer Yakuhin Ltd., Osaka, leading Bayer’s healthcare business in Japan.

Sebastian Guth’s professional career in the pharmaceuticals industry started in 2001 with Schering where he was Special Projects Leader for Asia and the Middle East. This led to his transfer to Schering Singapore Pte. as Managing Director for Malaysia, Singapore, and Vietnam the following year. Returning to Berlin in 2005, Mr. Guth was appointed Head of Strategy and Business Development for Schering’s European business. Following Bayer’s acquisition of Schering in 2006, he acted as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey from 2007, until his transfer to Japan in early 2011.

Born in 1974, Sebastian Guth is married and has three children.

Christi Shaw

Christi Shaw

Senior Vice President & President, Lilly Bio Medicines

Read more

More information coming soon...

Rob Koremans

Rob Koremans

CEO & President, TEVA Specialty Medicines

Read more

Dr. Rob Koremans has led Teva’s Global Specialty Medicines business as President and CEO since 2013.

A member of Teva’s Executive Committee (TEC), Rob provides input into the overall direction of the Company, and reports to the CEO. He leads an organization of 3000+ employees with 15 direct reports in key leadership positions. Since joining Teva, he has established four global therapeutic areas within Teva’s branded business unit, including CNS, Respiratory, Oncology and Women’s Health.

Rob previously served as President and CEO of Teva Pharmaceuticals Europe beginning in 2012, and established the management structure for branded products in Europe. This included the acquisition of exclusive rights to Copaxone from Sanofi, driving branded product sales which increased by 25%, and the launch of 6 new branded products.  In this role, he also focused on the development of PGT, Teva’s joint venture with P&G on its OTC business, achieving 20% growth in sales and operating profit in 2012.

Prior to joining Teva, Rob held senior executive positions at Sanofi, the Elsevier Group, Cryo-Save, Johnson & Johnson (Cilag AG), the Serono Group and Grunenthal GmbH. He received a medical degree from the Erasmus University of Rotterdam in 1988 and earned an executive MBA from Babson College in Massachusetts.  

A native of the Netherlands, he is married to a physician and is the father of three daughters. He brings his dedication and commitment as a physician and as business leader to a company that is focused on improving health. In leading his organization, Rob puts the patient at the center, as well as in his life personally.

Paul Perrault

Paul Perrault

CEO, CSL Limited

Read more

More information coming soon...

Giles Platford

Giles Platford

President, Europe and Canada Business Unit, Takeda

Read more

More information coming soon...

andrin_oswald

Andrin Oswald

Director – Life Sciences Partnerships, Global Health, Gates Foundation

Read more

More information coming soon...

Kabir Nath

Kabir Nath

President & CEO, Otsuka USA

Read more

More information coming soon...

julie_gerberding

Julie Gerberding

EVP & Chief Patient Officer, MSD

Read more

More information coming soon...

nathalie_moll

Nathalie Moll

Director General, EFPIA

Read more

More information coming soon...

Milind Kamkolkar

Milind Kamkolkar

Chief Data Officer, Sanofi

Read more

More information coming soon...

Mark Mallon

Mark Mallon

Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs, AstraZeneca

Read more

More information coming soon...

Andrew Baum

Andrew Baum

Managing Director Global Head of Healthcare Research, Citi

Read more

More information coming soon...

William H. Carson

William H. Carson

President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.

Read more

More information coming soon...

Bahija Jallal

Bahija Jallal

Executive Vice-President, MedImmune

Read more

More information coming soon...

Alfredo Barón de Juan

Alfredo Barón de Juan

EVP Global Commercial Operations, Almirall

Read more

More information coming soon...

Dr. Carey Adams

Dr. Carey Adams

CEO, UICC

Read more

More information coming soon...

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Bryon Matthews

Bryon Matthews

President and CEO, Miller Heiman Group

Read more

More information coming soon...

Hannelore Grams

Hannelore Grams

Head of Digital Excellence Europe and Canada, Takeda

Read more

More information coming soon...


Mark Mallon

Mark Mallon

Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs
AstraZeneca

Read more

More information coming soon...

Sandra Silvestri

Sandra Silvestri

Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit
Sanofi

Read more

More information coming soon...

Thomas D’Hooghe

Thomas D’Hooghe

Vice-President and Head Global Medical Affairs Fertility
Merck

Read more

More information coming soon...

Monica de Abadal

Monica de Abadal

Vice President Global Medical Affairs Services
Ipsen

Read more

More information coming soon...

Antonio Tataranni

Antonio Tataranni

Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit
Sanofi

Read more

More information coming soon...

Martina Muttke

Martina Muttke

Group Vice President, Head of International Medical Affairs
Shire

Read more

More information coming soon...

Ludovic Hacopian

Ludovic Hacopian

Worldwide Field Medical & Medical Effectiveness Head
BMS

Read more

More information coming soon...

Gundula Schneidewind

Gundula Schneidewind

Managing Director Belgium
Takeda

Read more

More information coming soon...

Pam Bacon

Pam Bacon

Executive Director Medical Affairs
Celgene

Read more

More information coming soon...

Victoria Ho

Victoria Ho

Worldwide Field Medical & Communications Lead
Bristol-Myers Squibb

Read more

More information coming soon...

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Sital Kotecha

Sital Kotecha

Director, Medical Strategy
Veeva Systems

Read more

More information coming soon...

Kumaran Krishnan

Kumaran Krishnan

Associate Director MSL and Digital Transformation
Teva

Read more

More information coming soon...

Emma Booth

Emma Booth

Europe Medical Strategic Planning & Operations
Amgen

Read more

More information coming soon...

Mike Spencer

Mike Spencer

Head of Real-World Evidence EMEA
Janssen

Read more

More information coming soon...

Felix Jackson

Felix Jackson

Founder
medCrowd

Read more

More information coming soon...

Hubert Bland

Hubert Bland

Country Medical Chair and Medical Head Diabetes and Cardiovascular
Sanofi UK

Read more

More information coming soon...

James Mawby

James Mawby

Head of Medical Affairs
Roche

Read more

More information coming soon...

Kim Maguire-Wright

Kim Maguire-Wright

Senior Solutions Consultant, Real World Evidence Solutions
PAREXEL

Read more

More information coming soon...

Jamie DeMaria

Jamie DeMaria

Senior Vice President
Medscape Education

Read more

More information coming soon...

Charlotte Moseley

Charlotte Moseley

Global Head
Complete HealthVizion

Read more

More information coming soon...

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Ian Greenway

Ian Greenway

Medical Affairs Director
Complete HealthVizion

Read more

More information coming soon...

Brian Jepson

Brian Jepson

Scientific Director
Complete HealthVizion

Read more

More information coming soon...

Barbara Isquith Arone

Barbara Isquith Arone

Vice President, Business Operations Center for Advanced Evidence Generation
IQVIA

Read more

More information coming soon...

Janice Haigh

Janice Haigh

VP Pricing & Market Access
PAREXEL

Read more

More information coming soon...

Eduardo Elorz

Eduardo Elorz

Former Oncology Global Medical Affairs Director
Eli Lilly

Read more

More information coming soon...


Steven Hildemann

Steven Hildemann

Global Chief Medical Officer
Merck

Read more

More information coming soon...

Kris Sterkens

Kris Sterkens

Company Groups Chairman, Europe, Middle East and Africa
Janssen

Read more

Since starting his career at Janssen in Belgium almost 30 years ago, Kris Sterkens has been part of many teams across EMEA, Asia Pacific, and the United States.

Moving on from his latest role as the Company Group Chairman of Janssen Asia Pacific, Kris was appointed Company Group Chairman of Europe, Middle East and Africa in June 2017. He was excited to return to his home country, Belgium, after spending over three years in Singapore since February 2014 for the Asia Pacific business.

Under Kris’ stewardship, Janssen Asia Pacific achieved notable milestones, including a return to growth in China and a successful business transformation in Japan. Kris also led teams in Korea, Australia, and New Zealand and successfully competed against new biosimilar entrant, in addition to achieving industry-leading growth in India. Throughout his career, Kris has demonstrated exceptional leadership and an ability to identify and develop talent. For instance, in Asia Pacific, he introduced Company Group Chairman’s Dialogue, a talent development programme which has engaged more than 100 emerging leaders.

Prior to that, Kris was leading the EMEA Strategy Organisation, alongside his role as Managing Director of the region’s Mid-Sized Markets. He was also the Managing Director for Janssen the Netherlands, the Benelux countries, and then Germany from 2007–2012.

Before his transition into General Management, Kris was Vice President, Finance and Chief Finance Officer (CFO) for Janssen EMEA.

Kris holds a Master’s degree in Applied Economics from the University of Antwerp, a Master's degree in Financial Management from the Flemish Institute of Management, and an MBA from the Solvay Business School in Brussels. Kris is fluent in Dutch, English, German, and French and has been a frequent speaker at business schools, medical and patient group events, and industry meetings.

Shreeram Aradhye

Shreeram Aradhye

Chief Medical Officer, Global Head of Medical Affairs, Novartis

Read more

More information coming soon...

Sebastian Guth

Sebastian Guth

Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals

Read more

Sebastian Guth is Executive Vice President and Chief Marketing Officer for Bayer Pharmaceuticals. In addition, he is responsible for the P&L and entire operations of Bayer's global Radiology Business Unit. Mr. Guth is a member of the Pharmaceuticals Executive Committee and Global Pharmaceuticals Development Committee.

Based in Berlin, Germany, Mr. Guth oversees global product strategy, marketing, market access and marketing operations for Bayer’s prescription pharmaceuticals portfolio. Bayer Pharmaceuticals’ portfolio focuses on highly innovative new launches and a broad range of established products for cardiology and women’s healthcare as well as for specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Radiology Business Unit develops and commercializes diagnostic imaging equipment together with the necessary contrast agents.

Before assuming his current role at Bayer Pharmaceuticals in October 2015, Mr. Guth was Chief Marketing Officer for Bayer’s General Medicine Business. Previously he served as President & Chief Executive Officer of Bayer Yakuhin Ltd., Osaka, leading Bayer’s healthcare business in Japan.

Sebastian Guth’s professional career in the pharmaceuticals industry started in 2001 with Schering where he was Special Projects Leader for Asia and the Middle East. This led to his transfer to Schering Singapore Pte. as Managing Director for Malaysia, Singapore, and Vietnam the following year. Returning to Berlin in 2005, Mr. Guth was appointed Head of Strategy and Business Development for Schering’s European business. Following Bayer’s acquisition of Schering in 2006, he acted as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey from 2007, until his transfer to Japan in early 2011.

Born in 1974, Sebastian Guth is married and has three children.

Christi Shaw

Christi Shaw

Senior Vice President & President, Lilly Bio Medicines

Read more

More information coming soon...

Rob Koremans

Rob Koremans

CEO & President, TEVA Specialty Medicines

Read more

Dr. Rob Koremans has led Teva’s Global Specialty Medicines business as President and CEO since 2013.

A member of Teva’s Executive Committee (TEC), Rob provides input into the overall direction of the Company, and reports to the CEO. He leads an organization of 3000+ employees with 15 direct reports in key leadership positions. Since joining Teva, he has established four global therapeutic areas within Teva’s branded business unit, including CNS, Respiratory, Oncology and Women’s Health.

Rob previously served as President and CEO of Teva Pharmaceuticals Europe beginning in 2012, and established the management structure for branded products in Europe. This included the acquisition of exclusive rights to Copaxone from Sanofi, driving branded product sales which increased by 25%, and the launch of 6 new branded products.  In this role, he also focused on the development of PGT, Teva’s joint venture with P&G on its OTC business, achieving 20% growth in sales and operating profit in 2012.

Prior to joining Teva, Rob held senior executive positions at Sanofi, the Elsevier Group, Cryo-Save, Johnson & Johnson (Cilag AG), the Serono Group and Grunenthal GmbH. He received a medical degree from the Erasmus University of Rotterdam in 1988 and earned an executive MBA from Babson College in Massachusetts.  

A native of the Netherlands, he is married to a physician and is the father of three daughters. He brings his dedication and commitment as a physician and as business leader to a company that is focused on improving health. In leading his organization, Rob puts the patient at the center, as well as in his life personally.

Paul Perrault

Paul Perrault

CEO, CSL Limited

Read more

More information coming soon...

Giles Platford

Giles Platford

President, Europe and Canada Business Unit, Takeda

Read more

More information coming soon...

andrin_oswald

Andrin Oswald

Director – Life Sciences Partnerships, Global Health, Gates Foundation

Read more

More information coming soon...

Kabir Nath

Kabir Nath

President & CEO, Otsuka USA

Read more

More information coming soon...

julie_gerberding

Julie Gerberding

EVP & Chief Patient Officer, MSD

Read more

More information coming soon...

nathalie_moll

Nathalie Moll

Director General, EFPIA

Read more

More information coming soon...

Milind Kamkolkar

Milind Kamkolkar

Chief Data Officer, Sanofi

Read more

More information coming soon...

Mark Mallon

Mark Mallon

Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs, AstraZeneca

Read more

More information coming soon...

Andrew Baum

Andrew Baum

Managing Director Global Head of Healthcare Research, Citi

Read more

More information coming soon...

William H. Carson

William H. Carson

President & CEO, Otsuka Pharmaceuticals Development & Commercialization, Inc.

Read more

More information coming soon...

Bahija Jallal

Bahija Jallal

Executive Vice-President, MedImmune

Read more

More information coming soon...

Alfredo Barón de Juan

Alfredo Barón de Juan

EVP Global Commercial Operations, Almirall

Read more

More information coming soon...

Dr. Carey Adams

Dr. Carey Adams

CEO, UICC

Read more

More information coming soon...

jean_luc_eisele

Jean-Luc Eiselé

CEO, World Heart Federation

Read more

More information coming soon...

Bryon Matthews

Bryon Matthews

President and CEO, Miller Heiman Group

Read more

More information coming soon...

Hannelore Grams

Hannelore Grams

Head of Digital Excellence Europe and Canada, Takeda

Read more

More information coming soon...

Mark Mallon

Mark Mallon

Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs
AstraZeneca

Read more

More information coming soon...

Sandra Silvestri

Sandra Silvestri

Senior Vice President, Head of Global Medical Affairs, General Medicine & Emerging Market Business Unit
Sanofi

Read more

More information coming soon...

Thomas D’Hooghe

Thomas D’Hooghe

Vice-President and Head Global Medical Affairs Fertility
Merck

Read more

More information coming soon...

Monica de Abadal

Monica de Abadal

Vice President Global Medical Affairs Services
Ipsen

Read more

More information coming soon...

Antonio Tataranni

Antonio Tataranni

Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit
Sanofi

Read more

More information coming soon...

Martina Muttke

Martina Muttke

Group Vice President, Head of International Medical Affairs
Shire

Read more

More information coming soon...

Ludovic Hacopian

Ludovic Hacopian

Worldwide Field Medical & Medical Effectiveness Head
BMS

Read more

More information coming soon...

Gundula Schneidewind

Gundula Schneidewind

Managing Director Belgium
Takeda

Read more

More information coming soon...

Pam Bacon

Pam Bacon

Executive Director Medical Affairs
Celgene

Read more

More information coming soon...

Victoria Ho

Victoria Ho

Worldwide Field Medical & Communications Lead
Bristol-Myers Squibb

Read more

More information coming soon...

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Sital Kotecha

Sital Kotecha

Director, Medical Strategy
Veeva Systems

Read more

More information coming soon...

Kumaran Krishnan

Kumaran Krishnan

Associate Director MSL and Digital Transformation
Teva

Read more

More information coming soon...

Emma Booth

Emma Booth

Europe Medical Strategic Planning & Operations
Amgen

Read more

More information coming soon...

Mike Spencer

Mike Spencer

Head of Real-World Evidence EMEA
Janssen

Read more

More information coming soon...

Felix Jackson

Felix Jackson

Founder
medCrowd

Read more

More information coming soon...

Hubert Bland

Hubert Bland

Country Medical Chair and Medical Head Diabetes and Cardiovascular
Sanofi UK

Read more

More information coming soon...

James Mawby

James Mawby

Head of Medical Affairs
Roche

Read more

More information coming soon...

Kim Maguire-Wright

Kim Maguire-Wright

Senior Solutions Consultant, Real World Evidence Solutions
PAREXEL

Read more

More information coming soon...

Jamie DeMaria

Jamie DeMaria

Senior Vice President
Medscape Education

Read more

More information coming soon...

Charlotte Moseley

Charlotte Moseley

Global Head
Complete HealthVizion

Read more

More information coming soon...

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Ian Greenway

Ian Greenway

Medical Affairs Director
Complete HealthVizion

Read more

More information coming soon...

Brian Jepson

Brian Jepson

Scientific Director
Complete HealthVizion

Read more

More information coming soon...

Barbara Isquith Arone

Barbara Isquith Arone

Vice President, Business Operations Center for Advanced Evidence Generation
IQVIA

Read more

More information coming soon...

Janice Haigh

Janice Haigh

VP Pricing & Market Access
PAREXEL

Read more

More information coming soon...

Eduardo Elorz

Eduardo Elorz

Former Oncology Global Medical Affairs Director
Eli Lilly

Read more

More information coming soon...

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription